Your Belgian gateway to leading-edge solutions across the radiopharmaceutical value-chain
An incredible year for Belgium’s radiopharmaceutical ecosystem ! As we scope out shared facilities to introduce at Quantum Biospace by BVI.EU to support biopharma segments driving the TechBio revolution, we’ve gathered the most important highlights for you below:
▶️Feb 2025: Framatome and IBA, partnered to develop an Astatine-211 Cyclotron Network in Europe and the USA
▶️Dec 2024: The IRE - Institute for radioelements announced arrival of a 30 MeV IBA cyclotron, enhancing self-sufficiency in Germanium-68 (Ge-68) production
▶️Dec 2024: Telix Pharmaceuticals Limited completed the installation of two new cyclotrons in Brussels South
▶️Oct 2024: CDMO SpectronRx inked a binding agreement to complete its first European radiolabeling plant at the Belgian Nuclear Research Center (SCK CEN)
▶️Sept 2024 : PANTERA secured €134M to scale up Actinium-225 production, targeting 100,000 patients by 2030
▶️March 2024 : Full-Life Technologies obtained a class IIa nuclear permit for its 4000m² radioisotope manufacturing facility from the Belgian Federal Agency for Nuclear Control
▶️Nov 2023 : SCK CEN laid foundation stone for CRF - Centralized Radiochemical Facility set to begin operations in 2026 and will scale up production of Lutetium-177 for 15,000 patients initially, with plans to reach 100,000 patients on the long-term
Discover Quantum Biospace profile on the Rad4Med.be, Radiation for Medicine website and follow us to learn more about the projects we are going to shape in the field of radiopharmacy.
